Complete Wegovy vs Mounjaro UK Pricing Breakdown
Wegovy vs Mounjaro UK: Why Hidden Fees Matter
When comparing Wegovy vs Mounjaro UK prices online, many pharmacies display attractive headline costs but add consultation fees, prescription charges, or processing costs during checkout. This makes genuine price comparison nearly impossible until you've completed their entire assessment process. EverydayMeds eliminates this frustration with complete price transparency — your Wegovy or Mounjaro cost includes clinical assessment, prescriber review, prescription generation, and temperature-controlled delivery.
The difference becomes significant over a typical weight management journey. Hidden consultation fees of £20-40 per order compound across dose escalations, potentially adding hundreds of pounds to your total treatment cost. Our transparent pricing for Wegovy vs Mounjaro UK means you can make informed decisions based on actual costs, not misleading introductory prices.
Wegovy vs Mounjaro UK: Complete Pricing Structure
Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. These prices include everything — apply discount code FIRST40 for new customers or DOSE25 for returning customers at checkout to reach these final costs. Our 2-pen bundles offer convenience for continuous supply: Intro Duo (0.25mg & 0.5mg) costs £169.99, while the Progress Duo (0.5mg & 1mg) is £189.99.
Mounjaro pricing follows a similar transparent structure, though specific costs depend on dose requirements determined during clinical assessment. Both Wegovy and Mounjaro are available through the same streamlined process at EverydayMeds, with identical assessment procedures and delivery standards. Your prescriber will help determine which medication suits your individual circumstances during the clinical review process.
Clinical Evidence Behind Wegovy vs Mounjaro UK Options
Wegovy's efficacy stems from the landmark STEP clinical trials, with STEP 1 demonstrating average weight loss of approximately 15% at 68 weeks when used alongside diet and exercise (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, highlighting additional health benefits beyond weight management.
Mounjaro operates through a dual-hormone mechanism as a GIP and GLP-1 receptor agonist, while Wegovy works solely on GLP-1 receptors. Both medications require prescription-only access following clinical assessment, ensuring appropriate patient selection and monitoring throughout treatment.
How Wegovy Works in Your Weight Management Journey
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormones. Once injected weekly, it reduces appetite by acting on brain appetite centres, promoting earlier satiety after smaller meals. The medication may also reduce food cravings and slow gastric emptying, helping you feel satisfied longer after eating. This biological mechanism supports sustainable weight management when combined with reduced-calorie diet and increased physical activity. Unlike appetite suppressant tablets, Wegovy's weekly injection provides consistent hormone-level regulation throughout the treatment period.
Streamlined Ordering Process for Wegovy vs Mounjaro UK
Both Wegovy and Mounjaro follow identical ordering procedures at EverydayMeds, ensuring fair comparison without process-related bias. Complete our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Your responses undergo prescriber review within 3 working days (or 24 hours with express service), ensuring clinical appropriateness before prescription generation. Once approved, your medication ships via next-day delivery using temperature-controlled cold-chain logistics, maintaining pharmaceutical integrity from our GPhC-registered pharmacy (#9012878) to your door.
Storage and Practical Considerations: Wegovy vs Mounjaro UK
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, versus Mounjaro's 21-day room temperature limit. Both medications require initial refrigerated storage at 2-8°C before first use. Wegovy uses Novo Nordisk's FlexTouch pen system with clear dose escalation markings, progressing from 0.25mg through to 2.4mg maintenance over 17 weeks. The structured dose escalation cannot be rushed, ensuring optimal tolerance and efficacy throughout your treatment journey.
Wegovy vs Mounjaro UK: Investment Transparency Analysis
Traditional pharmacies often separate medication costs from service fees, creating confusion when budgeting for long-term weight management. Our integrated pricing for both Wegovy and Mounjaro UK options includes all professional services required for safe prescription access. Calculate your complete treatment cost upfront, including dose escalation phases, without worrying about accumulated consultation charges.
This transparency becomes crucial when comparing the total investment required for either medication over 6-12 months. While individual dose costs vary, knowing your exact financial commitment helps make sustainable treatment decisions rather than discovering mounting service charges mid-treatment.
Start Your Weight Management Journey Today
Both Wegovy and Mounjaro are available through our transparent pricing structure, with new customer discount code FIRST40 or returning customer code DOSE25 applied at checkout. Our clinical team helps determine the most appropriate option during prescription review, considering your medical history and treatment preferences. Visit our Wegovy collection to begin your clinical assessment, or contact our patient support team for personalised guidance on medication selection. Every order includes comprehensive aftercare support throughout your weight management journey, backed by our GPhC-registered pharmacy standards (#9012878).
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
